Enlitic (ASX:ENL) DeferredTaxAndRevenue: A$0.00 Mil (As of Dec. 2025)


What is Enlitic DeferredTaxAndRevenue?

Enlitic ASX:ENL +16.67% DeferredTaxAndRevenue is A$0.00 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Enlitic's current deferred tax and revenue for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Enlitic DeferredTaxAndRevenue Related Terms

Enlitic DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Enlitic's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enlitic DeferredTaxAndRevenue Chart

Enlitic Annual Data
Trend Dec23 Dec24 Dec25
DeferredTaxAndRevenue
0.00 0.04 0.00

Enlitic Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
DeferredTaxAndRevenue 0.00 0.00 0.04 0.00 0.00
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of A$0.00 Mil mean?
Enlitic (ASX:ENL) has a DeferredTaxAndRevenue of A$0.00 Mil as of Dec. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Enlitic.
Is Enlitic's DeferredTaxAndRevenue too high?
Enlitic's current DeferredTaxAndRevenue is A$0.00 Mil.
How does Enlitic's DeferredTaxAndRevenue compare to VEEV and BTSG?
Enlitic's DeferredTaxAndRevenue of A$0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Healthcare Providers & Services company?
A good DeferredTaxAndRevenue depends on the Healthcare Providers & Services industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Enlitic. Enlitic's current DeferredTaxAndRevenue is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enlitic stock overvalued right now?
Enlitic (ASX:ENL) has a current DeferredTaxAndRevenue of A$0.00 Mil. The current DeferredTaxAndRevenue is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Enlitic (ASX:ENL), the current DeferredTaxAndRevenue is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enlitic Business Description

Address 1635 Foxtrail Drive, Suite 111A, Loveland, CO, USA, 80538
Enlitic Inc is the AI-enabled healthcare revolution. The company has developed an intelligent data framework that powers critical workflows, orchestrates data, and enables greater comprehension of what information resides in archives thereby unlocking new revenue opportunities, generating cost savings, and improving healthcare delivery. It provides solutions for Radiologists, IT Professionals, Executives, and Researchers. The Group has two operating segments: Software includes intelligently managing healthcare data using the power of artificial intelligence to expand capacity and improve clinical workflows, etc; and Migration services Transfer large volumes of imaging data to allow for the smooth transition of software solutions for healthcare vendors and providers and Migration services.